Literature DB >> 26374298

Cognitive function in idiopathic pulmonary fibrosis.

Melinda Bors1, Rade Tomic2, David M Perlman2, Hyun J Kim2, Timothy P M Whelan3.   

Abstract

The purpose of this study was to investigate whether there is evidence that individuals with severe idiopathic pulmonary fibrosis (IPF) have cognitive deficits when compared to individuals with healthy lungs. Participants completed five neuropsychological tests: Trail Making Test (TMT) A and B, Stroop Color Word Test (1, 2, 3), Hopkins Verbal Learning Test, Boston Naming Test, and Grooved Pegboard Test, additionally, the short form-36 and Beck Depression Index. Twelve participants (7 male, mean age 69.3, 9.4 years) comprised the severe IPF group defined by a diffusion capacity for carbon monoxide (DLCO) <30%. Thirty-four patients (22 male, mean age 63.2, 9.6 years) comprised the mild-to-moderate group with a DLCO >30%. Participating spouses (n = 15, 4 male) served as the control group and had a mean age of 66.0, 10.8 years. Controlling for gender and age, the severe group had a significantly longer mean TMT B time (69.4, 135.9 seconds) than the mild group and the control group (86.7 seconds vs 83.2 seconds; p = 0.004 and 0.008 respectively), suggesting inferior performance on tasks requiring speed divided attention. In addition, the severe group had a significantly lower number of correctly identified colors in the Stroop 3 test (22.4 vs 30.6 vs 38.6; p < 0.001), suggesting slower processing speeds when requiring suppression of a familiar response. Participants with severe IPF had worse cognitive function than mild IPF or control subjects. Further research is needed to explain these findings and to develop interventions tailored to address these deficits.
© The Author(s) 2015.

Entities:  

Keywords:  HRQOL; Interstitial lung disease; cognitive impairment; idiopathic pulmonary fibrosis (IPF)

Mesh:

Year:  2015        PMID: 26374298     DOI: 10.1177/1479972315603552

Source DB:  PubMed          Journal:  Chron Respir Dis        ISSN: 1479-9723            Impact factor:   2.444


  6 in total

1.  Are pulmonary fibrosis and Alzheimer's disease linked? Shared dysregulation of two miRNA species and downstream pathways accompany both disorders.

Authors:  Debomoy K Lahiri; Bryan Maloney; Nigel H Greig
Journal:  J Biol Chem       Date:  2017-12-08       Impact factor: 5.157

2.  The Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review.

Authors:  Alex Diamantopoulos; Emily Wright; Katerina Vlahopoulou; Laura Cornic; Nils Schoof; Toby M Maher
Journal:  Pharmacoeconomics       Date:  2018-07       Impact factor: 4.981

3.  Sedentary Time and Cognitive Impairment in Patients Using Long-Term Oxygen Therapy: A Cross-Sectional Study.

Authors:  Hiroki Annaka; Tomonori Nomura; Hiroshi Moriyama
Journal:  Int J Environ Res Public Health       Date:  2022-02-02       Impact factor: 3.390

4.  Cognitive Function and the Ability to Operate Long-Term Oxygen Therapy Equipment: An Exploratory Study.

Authors:  Hiroki Annaka; Tomonori Nomura; Hiroshi Moriyama
Journal:  Int J Environ Res Public Health       Date:  2022-08-28       Impact factor: 4.614

5.  Impact of moderate to severe obstructive sleep apnea on the cognition in idiopathic pulmonary fibrosis.

Authors:  Voicu Tudorache; Daniel Traila; Monica Marc; Cristian Oancea; Diana Manolescu; Emanuela Tudorache; Bogdan Timar; Alin Albai; Ovidiu Fira-Mladinescu
Journal:  PLoS One       Date:  2019-02-01       Impact factor: 3.240

6.  Patients with idiopathic pulmonary fibrosis with and without obstructive sleep apnea: differences in clinical characteristics, clinical outcomes, and the effect of PAP treatment.

Authors:  George Papadogiannis; Izolde Bouloukaki; Charalampos Mermigkis; Stylianos Michelakis; Christina Ermidou; Eleni Mauroudi; Violeta Moniaki; Nikolaos Tzanakis; Katerina M Antoniou; Sophia E Schiza
Journal:  J Clin Sleep Med       Date:  2021-03-01       Impact factor: 4.062

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.